The clinical picture of primary cutaneous diffuse large B-cell... | Download Scientific Diagram
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma | Nature Medicine
Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed | Haematologica
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study - The Lancet Healthy Longevity
Ibrutinib in B-cell lymphoma: single fighter might be enough? | Cancer Cell International | Full Text
Cureus | Systemic Aspergillosis: Radiological Findings in a Case With Diffuse Large B Cell Lymphoma Treated by Ibrutinib | Article
Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study | Indian Journal of Hematology and Blood Transfusion
Diffuse Large B-Cell Lymphoma | NEJM
Overall survival following Richter transformation on ibrutinib by line... | Download Scientific Diagram
Ibrutinib Boosts Survival in Younger Patients With Certain DLBCL Subtypes | MedPage Today
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma | Acta Pharmacologica Sinica
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
Frontiers | Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma: Molecular Therapy - Oncolytics
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy
AbbVie, Johnson & Johnson's Imbruvica comes up short in non-Hodgkin lymphoma trial | Fierce Pharma
B-cell receptor signaling in diffuse large B-cell lymphoma. | Semantic Scholar
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies | Cell Death & Disease
Cancers | Free Full-Text | Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas
The key signaling pathways implicated in diffuse large B cell lymphoma... | Download Scientific Diagram
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Gene Expression Affects Treatment Response With Ibrutinib in Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
JPM | Free Full-Text | Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies
Frontiers | The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
